PQ 1868
1868. Deputy Colm Burke asked the Minister for Health since the establishment of the rare diseases technology review committee (RDTRC) in 2018, the specific drugs that have been considered by the RDTRC and their recommendations, in tabular form; whether these drugs are now available to Irish patients; the timelines for each from EMA licence to availability; and if he will make a statement on the matter. [39003/23]
Introduced
11 September 2023
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
11 September 2023
Summary
1868. Deputy Colm Burke asked the Minister for Health since the establishment of the rare diseases technology review committee (RDTRC) in 2018, the specific drugs that have been considered by the RDTRC and their recommendations, in tabular form; whether these drugs are now available to Irish patients; the timelines for each from EMA licence to availability; and if he will make a statement on the matter. [39003/23]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 11 September 2023
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2023-09-11/1868/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2023-09-11/pq_1868